This information is accurate as of 17/7/2026. Please refer back to the website to ensure all reference information is current and up-to-date.

消息

4 月 14, 2022

Science: Pandemic propels global effort to study rare vaccine side effects

4 月 14, 2022

New immunisation reference page: Diphtheria

4 月 14, 2022

ATAGI advice on use of sedation for COVID-19 vaccination

4 月 13, 2022

Registrations now open for the April CVU mini event

3 月 31, 2022

Moderna: COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to ≤ 6 Years successfully meets its primary endpoint

3 月 30, 2022

ATAGI 日本脑炎病毒疫苗临床指南

3 月 30, 2022

Updated immunisation reference page: Rotavirus

3 月 30, 2022

ATAGI 关于冬季加强剂量 COVID-19 疫苗建议的声明

3 月 24, 2022

Sydney Institute for Infectious Diseases webinar recording now available: JEV outbreak in Australia – important insight for clinicians

3 月 24, 2022

Save the date for our first CVU mini event for 2022: Thursday 28 April 2022

3 月 24, 2022

Vocal cord dysfunction/inducible laryngeal obstruction(s) mimicking anaphylaxis during SARS-CoV-2 (COVID-19) vaccination

3 月 24, 2022

Updated immunisation reference pages: Influenza and Influenza vaccine: frequently asked questions

3 月 17, 2022

The Conversation: Flu, COVID and flurona: what we can and can’t expect this winter

3 月 17, 2022

《纽约时报》：在非洲，多种枪击事件推动了不确定的新冠疫苗接种进程

3 月 17, 2022

CDC: Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years

3 月 17, 2022

CDC: Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort

3 月 10, 2022

New reference page: Japanese encephalitis

3 月 10, 2022

New global vaccine trial launched to evaluate fractional COVID-19 booster shots

分享这个